KR20150035597A - 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물 - Google Patents

염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물 Download PDF

Info

Publication number
KR20150035597A
KR20150035597A KR1020147034760A KR20147034760A KR20150035597A KR 20150035597 A KR20150035597 A KR 20150035597A KR 1020147034760 A KR1020147034760 A KR 1020147034760A KR 20147034760 A KR20147034760 A KR 20147034760A KR 20150035597 A KR20150035597 A KR 20150035597A
Authority
KR
South Korea
Prior art keywords
pain
zoledronic acid
human
administering
need
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147034760A
Other languages
English (en)
Korean (ko)
Inventor
헤리엇 타부토
Original Assignee
안테씨프 바이오벤쳐스 투 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 안테씨프 바이오벤쳐스 투 엘엘씨 filed Critical 안테씨프 바이오벤쳐스 투 엘엘씨
Publication of KR20150035597A publication Critical patent/KR20150035597A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020147034760A 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물 Ceased KR20150035597A (ko)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US201261646538P 2012-05-14 2012-05-14
US61/646,538 2012-05-14
US201261647478P 2012-05-15 2012-05-15
US61/647,478 2012-05-15
US201261654292P 2012-06-01 2012-06-01
US201261654383P 2012-06-01 2012-06-01
US61/654,383 2012-06-01
US61/654,292 2012-06-01
US201261655541P 2012-06-05 2012-06-05
US201261655527P 2012-06-05 2012-06-05
US61/655,527 2012-06-05
US61/655,541 2012-06-05
US201361762225P 2013-02-07 2013-02-07
US61/762,225 2013-02-07
US201361764563P 2013-02-14 2013-02-14
US61/764,563 2013-02-14
US201361767676P 2013-02-21 2013-02-21
US201361767647P 2013-02-21 2013-02-21
US61/767,676 2013-02-21
US61/767,647 2013-02-21
US201361803721P 2013-03-20 2013-03-20
US61/803,721 2013-03-20
PCT/US2013/040939 WO2013173330A1 (en) 2012-05-14 2013-05-14 Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020167032879A Division KR20160139050A (ko) 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물

Publications (1)

Publication Number Publication Date
KR20150035597A true KR20150035597A (ko) 2015-04-06

Family

ID=49549077

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020147034760A Ceased KR20150035597A (ko) 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물
KR1020167032879A Ceased KR20160139050A (ko) 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물
KR1020197000076A Ceased KR20190004381A (ko) 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020167032879A Ceased KR20160139050A (ko) 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물
KR1020197000076A Ceased KR20190004381A (ko) 2012-05-14 2013-05-14 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물

Country Status (21)

Country Link
US (5) US20130303486A1 (https=)
EP (2) EP2849758B1 (https=)
JP (2) JP2015518828A (https=)
KR (3) KR20150035597A (https=)
CN (2) CN109331027A (https=)
AU (3) AU2013262995B2 (https=)
CA (2) CA2873742C (https=)
CY (1) CY1120503T1 (https=)
DK (1) DK2849758T3 (https=)
ES (1) ES2667535T3 (https=)
HK (1) HK1255373A1 (https=)
HR (1) HRP20180606T1 (https=)
HU (1) HUE038905T2 (https=)
LT (1) LT2849758T (https=)
NZ (1) NZ702414A (https=)
PL (1) PL2849758T3 (https=)
PT (1) PT2849758T (https=)
RS (1) RS57294B1 (https=)
SI (1) SI2849758T1 (https=)
SM (1) SMT201800212T1 (https=)
WO (1) WO2013173330A1 (https=)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
DK2459176T3 (en) 2009-07-31 2017-12-04 Gruenenthal Gmbh Crystallization process and bioavailability
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
US10034890B2 (en) 2012-05-14 2018-07-31 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9782421B1 (en) 2012-05-14 2017-10-10 Antecip Bioventures Ii Llc Neridronic acid molecular complex for treating complex regional pain syndrome
US9956238B2 (en) 2014-05-15 2018-05-01 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US10016446B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US9820999B2 (en) 2012-05-14 2017-11-21 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US9694023B2 (en) 2012-05-14 2017-07-04 Antecip Bioventures Ii Llc Methods for the safe administration of imidazole or imidazolium compounds
US9867839B2 (en) 2012-05-14 2018-01-16 Antecip Bioventures Ii Llc Osteoclast inhibitors for joint conditions
US10413560B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US8802658B2 (en) 2012-05-14 2014-08-12 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US9616078B2 (en) 2012-05-14 2017-04-11 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US10028908B2 (en) 2012-05-14 2018-07-24 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9877977B2 (en) 2012-05-14 2018-01-30 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9827256B2 (en) 2014-05-27 2017-11-28 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating lower back pain
US9675626B2 (en) 2012-05-14 2017-06-13 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9717747B2 (en) 2012-05-14 2017-08-01 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US9861648B2 (en) 2012-05-14 2018-01-09 Antecip Boiventures Ii Llc Osteoclast inhibitors for knee conditions
US9827192B2 (en) 2012-05-14 2017-11-28 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10173986B2 (en) 2012-05-14 2019-01-08 Antecip Bioventures Ii Llc Methods for the safe administration of imidazole or imidazolium compounds
US10463682B2 (en) 2012-05-14 2019-11-05 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US9999629B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10493085B2 (en) 2012-05-14 2019-12-03 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US8865757B1 (en) 2014-05-28 2014-10-21 Antecip Bioventures Ii Llp Therapeutic compositions comprising imidazole and imidazolium compounds
US9669040B2 (en) 2012-05-14 2017-06-06 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9655908B2 (en) 2012-05-14 2017-05-23 Antecip Bioventures Ii Llc Neridronic acid molecular complex for treating complex regional pain syndrome
US9707245B2 (en) 2012-05-14 2017-07-18 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US9789128B2 (en) 2012-05-14 2017-10-17 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10016445B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9844559B2 (en) 2012-05-14 2017-12-19 Antecip Bioventures Ii Llc Neridronic acid for treating bone marrow lesions
US9662343B2 (en) 2012-05-14 2017-05-30 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9956237B2 (en) 2012-05-14 2018-05-01 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US9700570B2 (en) 2014-05-27 2017-07-11 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9949993B2 (en) 2012-05-14 2018-04-24 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9211257B2 (en) 2012-05-14 2015-12-15 Antecip Bioventures Ii Llc Osteoclast inhibitors for knee conditions
US9901589B2 (en) 2012-05-14 2018-02-27 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US20140349974A1 (en) * 2014-08-12 2014-11-27 Antecip Bioventures Ii Llc Zoledronic acid dosage forms for the treatment of pain
US9999628B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US9867840B2 (en) 2014-05-27 2018-01-16 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9427403B2 (en) 2012-05-14 2016-08-30 Antecip Bioventures Ii Llc Methods for the safe administration of imidazole or imidazolium compounds
US10111837B2 (en) 2012-05-14 2018-10-30 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds
US9925203B2 (en) 2012-05-14 2018-03-27 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9943531B2 (en) 2014-08-08 2018-04-17 Antecip Bioventures Ii Llc Osteoclast inhibitors such as zoledronic acid for low back pain treatment
WO2015184003A1 (en) * 2014-05-27 2015-12-03 Antecip Bioventures Ii Llp Osteoclast inhibitors for pain
US10028969B2 (en) 2012-05-14 2018-07-24 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10413561B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US10350227B2 (en) 2012-05-14 2019-07-16 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US9795622B2 (en) 2012-05-14 2017-10-24 Antecip Bioventures Ii Llc Neridronic acid for treating pain associated with a joint
US10080765B2 (en) 2012-05-14 2018-09-25 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US9289441B2 (en) 2014-08-08 2016-03-22 Antecip Bioventures Ii Llc Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US9770457B2 (en) 2012-05-14 2017-09-26 Antecip Bioventures Ii Llc Neridronic acid for treating bone marrow lesion
US9707247B2 (en) 2012-05-14 2017-07-18 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US9956234B2 (en) 2012-05-14 2018-05-01 Antecip Bioventures Ii Llc Osteoclast inhibitors for joint conditions
US9895383B2 (en) 2012-05-14 2018-02-20 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10092581B2 (en) 2014-05-15 2018-10-09 Antecip Bioventures Ii Llc Osteoclast inhibitors such as zoledronic acid for low back pain treatment
US10004756B2 (en) 2014-05-15 2018-06-26 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10039773B2 (en) 2012-05-14 2018-08-07 Antecip Bioventures Ii Llc Neridronic acid for treating arthritis
CN104969556A (zh) 2013-01-08 2015-10-07 Lg电子株式会社 处理视频信号的方法和设备
SG10201609548UA (en) * 2013-10-25 2016-12-29 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
CN106456610A (zh) * 2014-05-27 2017-02-22 安泰赛普生物风投二代有限责任公司 用于疼痛的破骨细胞抑制剂
CA2950443A1 (en) * 2014-05-27 2015-12-03 Antecip Bioventures Ii Llc Osteoclast inhibitors for pain
US9127069B1 (en) 2014-06-11 2015-09-08 Antecip Bioventures LLC Compositions comprising rank/rankl antagonists and related compounds for treating pain
KR20210149861A (ko) * 2014-05-27 2021-12-09 안테씨프 바이오벤쳐스 투 엘엘씨 통증용 파골 세포 억제제
US20170182072A1 (en) * 2014-05-27 2017-06-29 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US9079927B1 (en) 2014-05-27 2015-07-14 Antecip Bioventures Ii Llc Substituted imidazolium compounds for treating disease
US9688765B2 (en) 2014-06-11 2017-06-27 Antecip Bioventures Ii Llc Methods using RANK/RANKL antagonist antibodies for treating pain
SI3206694T1 (sl) * 2014-10-15 2020-11-30 Abiogen Pharma Spa Uporaba neridronske kisline ali njene soli za zdravljenje osteoartroze
MX2018002627A (es) * 2015-09-18 2018-12-17 Gruenenthal Chemie Metodo de cristalizacion y biodisponibilidad.
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability
US20190328755A1 (en) * 2018-04-30 2019-10-31 Grunenthal Gmbh Methods of treating complex regional pain syndrome (crps) or symptoms comprising administration of neridronic acid
CN109908159B (zh) * 2019-03-15 2021-12-07 暨南大学 唑来膦酸和有机硒化合物联用在制备抗肿瘤药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US6579860B1 (en) * 1998-12-25 2003-06-17 Toray Industries, Inc. Interleukin-6 production inhibitors
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
CA2478317A1 (en) * 2002-03-04 2003-09-18 Medimmune, Inc. Methods of preventing or treating disorders by administering an integrin .alpha.v.beta.3 antagonist in combination with an hmg-coa reductase inhibitor or a bisphosphonate
US7875597B2 (en) * 2002-07-24 2011-01-25 New York University Treatment of spinal mechanical pain
CN1705485A (zh) * 2002-10-15 2005-12-07 诺瓦提斯公司 施用双膦酸类化合物的方法
EP1612212A1 (en) * 2003-07-03 2006-01-04 Teva Pharmaceutical Industries Ltd Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
AR046773A1 (es) * 2003-12-23 2005-12-21 Novartis Ag Formulaciones farmaceuticas de bisfosfonatos
JPWO2005072747A1 (ja) * 2004-02-02 2007-09-13 小野薬品工業株式会社 骨吸収抑制剤
KR20060134216A (ko) * 2004-04-16 2006-12-27 에미스페어 테크놀로지스, 인코포레이티드 활성제 전달을 위한 8-(2-히드록시페녹시)옥틸디에탄올아민및 그의 염
JP2007536235A (ja) * 2004-05-06 2007-12-13 メルク　エンド　カムパニー　インコーポレーテッド イヌにおいて関節炎状態を治療するための方法
DK2283825T3 (da) * 2004-05-24 2022-06-27 Theramex Hq Uk Ltd Enterisk fast oral doseringsform af en bisfosfonat indeholdende et chelateringsmiddel
CN101198316A (zh) * 2005-03-17 2008-06-11 伊兰制药国际有限公司 纳米微粒双膦酸盐组合物
KR101191322B1 (ko) * 2006-04-07 2012-10-16 메리온 리서치 Ⅲ 리미티드 증진제를 함유하는 고형 경구용 투여 제형
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates
WO2011097269A1 (en) * 2010-02-06 2011-08-11 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US8980868B2 (en) * 2009-07-31 2015-03-17 Thar Pharmaceuticals, Inc. Oral forms of a phosphonic acid derivative

Also Published As

Publication number Publication date
NZ702414A (en) 2016-10-28
EP2849758B1 (en) 2018-04-04
HUE038905T2 (hu) 2018-12-28
EP2849758A1 (en) 2015-03-25
PL2849758T3 (pl) 2018-08-31
KR20160139050A (ko) 2016-12-06
EP3323418A1 (en) 2018-05-23
PT2849758T (pt) 2018-05-09
AU2016256701B2 (en) 2018-05-10
US20130303486A1 (en) 2013-11-14
LT2849758T (lt) 2018-07-25
US20160151398A1 (en) 2016-06-02
HK1255373A1 (en) 2019-08-16
ES2667535T3 (es) 2018-05-11
CY1120503T1 (el) 2019-07-10
CA2987470A1 (en) 2013-11-21
JP2018127477A (ja) 2018-08-16
CA2873742A1 (en) 2013-11-21
AU2013262995A1 (en) 2014-12-18
SMT201800212T1 (it) 2018-07-17
HRP20180606T1 (hr) 2018-06-29
CN109331027A (zh) 2019-02-15
AU2013262995B2 (en) 2016-09-01
CN104349781A (zh) 2015-02-11
AU2018214132A1 (en) 2018-08-30
US20130303485A1 (en) 2013-11-14
SI2849758T1 (en) 2018-07-31
US20130303488A1 (en) 2013-11-14
US20130303487A1 (en) 2013-11-14
AU2016256701A1 (en) 2016-11-24
CA2873742C (en) 2018-01-16
AU2018214132B2 (en) 2019-07-11
KR20190004381A (ko) 2019-01-11
EP2849758A4 (en) 2015-12-30
WO2013173330A1 (en) 2013-11-21
JP2015518828A (ja) 2015-07-06
RS57294B1 (sr) 2018-08-31
DK2849758T3 (en) 2018-05-14

Similar Documents

Publication Publication Date Title
KR20150035597A (ko) 염증성 통증 및 관련 병태의 경감을 위한, 졸레드론산 또는 관련 화합물을 포함하는 조성물
KR101739244B1 (ko) 질병의 치료를 위한, 졸레드론산 또는 관련 화합물의 경구 투여용 조성물
US9616077B2 (en) Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US20160235772A1 (en) Dosage Forms for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease
AU2014340649A1 (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
HK40002583A (en) Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
WO2016172453A1 (en) Pharmacodynamic effects after oral administration of zoledronic acid or related compounds

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141211

Patent event code: PA01051R01D

Comment text: International Patent Application

AMND Amendment
PG1501 Laying open of application
A201 Request for examination
A302 Request for accelerated examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160418

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20160418

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

AMND Amendment
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20160523

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160901

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20160523

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20160901

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20160715

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20160510

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20160418

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20141215

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20161024

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20161004

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20160901

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160715

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20160523

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160510

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160418

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20141215

A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20161124

PJ0201 Trial against decision of rejection

Patent event date: 20161124

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20161024

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Patent event date: 20160901

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2016101006639

Request date: 20161124

J301 Trial decision

Free format text: TRIAL NUMBER: 2016101006639; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20161124

Effective date: 20170323

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20170323

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20161124

Decision date: 20170323

Appeal identifier: 2016101006639